Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty

Completed · Not applicable

Conditions studied: Osteoarthritis, Hip, Joint Deformities, Acquired, Hip Dislocation, Congenital, Osteonecrosis, Arthritis, Rheumatoid

In brief

The purpose of this study is to establish whether or not there is a clinical advantage to the use of Aquamantys® System from Medtronic Advanced Energy (formerly Salient Surgical Technologies) in patients undergoing primary total hip arthroplasty via the anterior supine intermuscular surgical approach in terms of blood loss, transfusion and wound healing. Wound healing will be assessed by a blinded observer and based upon a simple and subjective criteria: a) as expected, b) better than expected or c) worse than expected. The blinded observer is experienced in the care of the surgical patient and wound evaluation.

Key facts

Study ID

NCT01583465

Run by

Joint Implant Surgeons, Inc.

People needed

200

Starts

2009-10-01

Expected to finish

2011-09-01

Last updated by the study team

2012-04-24

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Undergoing primary unilateral total hip arthroplasty via the anterior supine intermuscular approach
• Patient is willing and able to complete all follow-up visits at 6 weeks and 1 year

You may not qualify if…

• Patients with pre-existing known coagulopathy
• Patients on chronic Coumadin (Warfarin) therapy
• Patients receiving erythropoietin therapy for anemia

Where it is running

• Joint Implant Surgeons, Inc. — New Albany, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.